Skip to content

Study · Not a test of the peptide alone · 1983

1 result

Synthesis of the C-terminal half of thymosin alpha 1 by the polymeric reagent method.

Mokotoff M, Patchornik A

International journal of peptide and protein research1 Feb 1983Cited by 11 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01LabNot a test of Thymosin alpha-1 aloneIn vitro (cell-free)Other

    The C-terminal half of thymosin alpha‑1, residues 15-28, was synthesised with polymer-bound 1-hydroxybenzotriazole (PHBT) activation of each coupling step.

    In plain wordsIn lab chemistry, the second half of thymosin alpha‑1 was made with a polymer-supported coupling method.

    Outcome
    Not applicableSynthesis of thymosin alpha 1 (15-28) with PHBT
    Study

    n: not reported in source

    Polymeric reagent peptide synthesis
    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    This was demonstrated by the synthesis of thymosin alpha 1 (15-28)
    1 context sentence
    Summary · context
    After appropriate deblocking of 2, segments 2 and 3 were coupled by the DCC-HOBT method, followed by complete deblocking and ion-exchange chromatographic purification, affording the C-terminal half of thymosin alpha 1, H-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH (1).

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.